IS ANTI-FACTOR XA ACTIVITY IMPORTANT

被引：0
|
作者：
HEMKER, HC [1 ]
机构：
[1] STATE UNIV LIMBURG,CTR BIOMED,DEPT BIOCHEM,6200 MD MAASTRICHT,NETHERLANDS
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1990年 / 116卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] HEPARIN AND LOW-MOLECULAR WEIGHT HEPARIN - IS ANTI-FACTOR XA ACTIVITY IMPORTANT
    LANE, DA
    RYAN, K
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1989, 114 (04): : 331 - 333
  • [2] ANTI-FACTOR XA ACTIVITY MEASURED WITH AMIDOLYTIC METHODS
    ODEGARD, OR
    LIE, M
    ABILDGAARD, U
    [J]. HAEMOSTASIS, 1976, 5 (05) : 265 - 275
  • [3] ANTI-FACTOR XA ACTIVITY OF HEPARAN-SULFATE
    THOMAS, DP
    MERTON, RE
    BARROWCLIFFE, TW
    MULLOY, B
    JOHNSON, EA
    [J]. THROMBOSIS RESEARCH, 1979, 14 (2-3) : 501 - 506
  • [4] The distribution of anti-factor Xa activity value, PT and APTT at peak and trough times in patients with direct anti-factor Xa inhibitors
    Ono, R.
    Fukushima, K.
    Yamazaki, T.
    Takahashi, H.
    Hori, Y.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3368 - 3368
  • [5] STABILITY OF ANTI-FACTOR XA ACTIVITY AFTER SAMPLE STORAGE
    Vermeiren, Pauline
    Vandevelde, Arne
    Devreese, Katrien M. J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 192 - 193
  • [6] Comparison of Methods to Determine Rivaroxaban anti-factor Xa activity
    Rathbun, Suman
    Tafur, Alfonso
    Grant, Russell
    Esmon, Naomi
    Mauer, Karin
    Marlar, Richard A.
    [J]. THROMBOSIS RESEARCH, 2015, 135 (02) : 394 - 397
  • [7] Anti-factor Xa activities of zingerone with anti-platelet aggregation activity
    Lee, Wonhwa
    Ku, Sae-Kwang
    Kim, Mi-Ae
    Bae, Jong-Sup
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2017, 105 : 186 - 193
  • [8] Synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities
    Xu, Yongmei
    Stancanelli, Eduardo
    Su, Guowei
    Liu, Jian
    [J]. GLYCOBIOLOGY, 2023, 33 (11) : 1057 - 1057
  • [9] Reproducibility of the anti-Factor Xa and anti-Factor IIa assays applied to enoxaparin solution
    Martinez, Celine
    Savadogo, Adama
    Agut, Christophe
    Anger, Pascal
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 81-82 : 138 - 145
  • [10] Andexanet-α reduces anti-factor Xa activity, improves haemostasis
    [J]. Reactions Weekly, 2019, 1740 (1) : 6 - 6
12345